Synthesis and in vitro antiplasmodial activities of fluoroquinolone analogsDIXIT, Sandeep K; MISHRA, Nidhi; SHARMA, Manish et al.European journal of medicinal chemistry. 2012, Vol 51, pp 52-59, issn 0223-5234, 8 p.Article

Anaphylactoid reaction to ciprofloxacinHO, Dora Y; SONG, Jessica C; WANG, Clifford C et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1018-1023, issn 1060-0280, 6 p.Article

Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: Relevance of DNA and protein interactions for their mechanism of actionGOUVEA, Ligiane R; GARCIA, Luciene S; LACHTER, Daniela R et al.European journal of medicinal chemistry. 2012, Vol 55, pp 67-73, issn 0223-5234, 7 p.Article

Pharmacokinetics and tolerability of prulifloxacin after single oral administrationPICOLLO, Rossella; BRION, Nils; GUALANO, Virginie et al.Arzneimittel-Forschung. 2003, Vol 53, Num 3, pp 201-205, issn 0004-4172, 5 p.Article

Solubility of norfloxacin and ofloxacin in supercritical carbon dioxideCHIM, Rita; MARCENEIRO, Sofia; BRAGA, Mara E. M et al.Fluid phase equilibria. 2012, Vol 331, pp 6-11, issn 0378-3812, 6 p.Article

Pharmacodynamic modeling of Carbapenems and fluoroquinolones against Bacteria that produce extended-spectrum beta-lactamasesMOCZYGEMBA, Leticia R; FREI, Christopher R; BURGESS, David S et al.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1800-1807, issn 0149-2918, 8 p.Article

Fluoroquinolones and anaerobesSTEIN, Gary E; GOLDSTEIN, Ellie J. C.Clinical infectious diseases. 2006, Vol 42, Num 11, pp 1598-1607, issn 1058-4838, 10 p.Article

Les effets indésirables des fluoroquinolones : Ils sont aussi psychiatriques !CHAGNON, André.Concours médical (Paris). 2006, Vol 128, Num 33-34, pp 1391-1392, issn 0010-5309, 2 p.Article

Classification of fluoroquinolonesNABER, K. G; ADAM, D.International journal of antimicrobial agents. 1998, Vol 10, Num 4, pp 255-257, issn 0924-8579Article

Les fluoroquinolones = FluoroquinolonesDAMAS, P.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 1, pp 50-52, issn 0370-629XArticle

Effect of N-1/C-8 Ring Fusion and C-7 Ring Structure on Fluoroquinolone LethalityMALIK, Muhammad; MARKS, Kevin R; SCHWANZ, Heidi A et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5214-5221, issn 0066-4804, 8 p.Article

Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational interventionLACOMBE, K; CARIOU, S; TILLEUL, P et al.European journal of clinical microbiology & infectious diseases (Print). 2005, Vol 24, Num 1, pp 6-11, issn 0934-9723, 6 p.Article

The role of clonality in the global spread of fluoroquinolone-resistant bacteriaKLUGMAN, Keith P.Clinical infectious diseases. 2003, Vol 36, Num 6, pp 783-785, issn 1058-4838, 3 p.Article

Antistaphylococcal Activities of the New Fluoroquinolone JNJ-Q2MORROW, Brian J; ABBANAT, Darren; BAUM, Ellen Z et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5512-5521, issn 0066-4804, 10 p.Article

Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agentsPERIC, Mihaela; JACOBS, Michael R; APPELBAUM, Peter C et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 3188-3192, issn 0066-4804, 5 p.Article

Effets indésirables neuropsychiatriques des fluoroquinolones : Un risque méconnuCHIFFOLEAU, Anne; NOWOCZYN, Marie; JACOB, Carine et al.Concours médical (Paris). 2008, Vol 130, Num 1, pp 31-33, issn 0010-5309, 3 p.Article

Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection modelsPATEL, Mahesh V; DE SOUZA, Noel J; GUPTE, Shrikant V et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4754-4761, issn 0066-4804, 8 p.Article

Fluoroquinolone-associated tendinopathy: A critical review of the literatureKHALIQ, Yasmin; ZHANEL, George G.Clinical infectious diseases. 2003, Vol 36, Num 11, pp 1404-1410, issn 1058-4838, 7 p.Article

Fluoroquinolone use in childrenSABHARWAL, Vishakha; MARCHANT, Colin D.The Pediatric infectious disease journal. 2006, Vol 25, Num 3, pp 257-258, issn 0891-3668, 2 p.Article

Quand utiliser une fluoroquinolone systémique ?ANSART, Séverine; NICOLAS, Xavier; PENNEC, Yvon L et al.MT. Médecine thérapeutique. 2005, Vol 11, Num 1, pp 14-17, issn 1264-6520, 4 p.Article

Innovations pharmacologiques, le modèle des fluoroquinolones = Pharmacological innovations, the fluoroquinolone modelBERGOGNE-BEREZIN, E.La Presse médicale (1983). 2003, Vol 32, Num 10, pp 466-469, issn 0755-4982, 4 p.Article

Les fluoroquinolones de troisième et quatrième générations = Third and fourth fluoroquinolones generationsROSSI, C; STERNON, J.Revue médicale de Bruxelles. 2001, Vol 22, Num 5, pp 443-456, issn 0035-3639Article

Recent developments in fluoroquinolone phototoxicityMAN, I; TRAYNOR, N. J; FERGUSON, J et al.Photodermatology photoimmunology & photomedicine. 1999, Vol 15, Num 1, pp 32-33, issn 0905-4383Article

Fluoroquinolone antibiotics in the environmentSUKUL, Premasis; SPITELLER, Michael.Reviews of environmental contamination and toxicology. 2007, Vol 191, pp 131-162, issn 0179-5953, 32 p.Article

Challenges in Assessing Microbial Susceptibility and Predicting Clinical Response to Newer-Generation FluoroquinolonesSEGRETI, John; JONES, Ronald N; BERTINO, Joseph S et al.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 1, pp 3-11, issn 1080-7683, 9 p.Article